Shareholder Alert: Ademi LLP investigates whether Asensus Surgical, Inc. has obtained a Fair Price for its Public Shareholders

Core Viewpoint - Ademi LLP is investigating Asensus Surgical for potential breaches of fiduciary duty and other legal violations related to its transaction with KARL STORZ, where shareholders will receive only $0.35 per share in cash [1] Group 1: Transaction Details - Asensus Surgical shareholders will receive $0.35 per share in cash as part of the transaction [1] - The transaction agreement imposes significant penalties on Asensus Surgical for accepting competing bids, thereby limiting competition [1] - Insiders of Asensus Surgical are set to receive substantial benefits through change of control arrangements [1] Group 2: Investigation Focus - The investigation is centered on the conduct of Asensus Surgical's board of directors and whether they are fulfilling their fiduciary duties to all shareholders [1]